Multivariant Transcriptome Analysis Identifies Modules and Hub Genes Associated with Poor Outcomes in Newly Diagnosed Multiple Myeloma Patients

SIMPLE SUMMARY: Multiple myeloma (MM) is a cancer of plasma cells with a five-year survival rate of 53%. MM is a heterogeneous disease with diverse clinical courses, consistent with the variable efficacy of therapeutic strategies and the development of chemoresistance. We used bioinformatic tools to...

Descripción completa

Detalles Bibliográficos
Autores principales: Adebayo, Olayinka O., Dammer, Eric B., Dill, Courtney D., Adebayo, Adeyinka O., Oseni, Saheed O., Griffen, Ti’ara L., Ohandjo, Adaugo Q., Yan, Fengxia, Jain, Sanjay, Barwick, Benjamin G., Singh, Rajesh, Boise, Lawrence H., Lillard, Jr., James W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9104534/
https://www.ncbi.nlm.nih.gov/pubmed/35565356
http://dx.doi.org/10.3390/cancers14092228

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9104534/
https://www.ncbi.nlm.nih.gov/pubmed/35565356
http://dx.doi.org/10.3390/cancers14092228

Ejemplares similares